Altogether, while the observations in PC indicate that variant status of HSD3B1 has limited impact on the tumor-intrinsic genome, HSD3B1 variant status may impact the tumor genome in other cancers and different clinical settings. This evidence concerns the gene HSD3B1 and neoplasm.